None listed
Conditions
Brief summary
The incidence of preeclampsia is rising in Australia due to increasing numbers of pregnancies in women at high risk for this condition. Our understanding of the pathophysiology is still unclear and the clinical and pathalogical classifications are inconsistent. In particular, the inconsistency in classification makes the management and follow-up of patients with preeclampsia challenging. Various studies have measured haemodynamic, vascular physiology and biochemical markers individually , however studies correlating these measurements are few. This project will comprehensively characterise the cardiovascular haemodynamic and endothelial function changes that occur in preeclampsia. From this we will correlate these changs to the various clnical presentations of preeclampsia in an attempt to find a better way to classify and risk stratify this life threatening condition. The ultimate aim is to gain a better understanding of the pathophysiology of preeclampsia and translate this into better management strategies in the future.
Interventions
Observational study of cardiovascular function to be performed in the third trimester of pregnancy and 6 months post-partum period. Pregnant women with preeclampsia, pregant women with pre-existing hypertension and pregnant women without hypertension in preganancy will all be prospectively enrolled to this study. Parameters to be measured include plasma and urine biomarkers of placental and endothelial function, functional measures of small and large vessel reactivity (using aplanation tanometry and laser doppler iontophoresis) and echocardiogaphical parameters of systolic and diastolic function.
Sponsors
Eligibility
Inclusion criteria
Pregnant women more then 32 weeks pregnant. They will be divided into three groups: Those diagnosed with preeclampsia as defined by the "international society for the study of hypertension in pregnancy" guidelines, those with pre-existing hypertension and those who are normotoensive on no antihypertensive medication.
Exclusion criteria
1. unable to give informed consent 2. pre-pregnancy cardiovascular disease or diabetes 3. chronic renal disease